Getting to a Lifetime Genetic Textbook for Treating Disease

  • Published on: April 22, 2022
  • Article
By Haim Neerman As a society, how much should be invested in creating a “transformative textbook of medicine, with insights…

Variantyx Licenses IBM Technologies That Leverage AI for Somatic Analysis

  • Published on: April 21, 2022
  • News
December 22, 2020 Variantyx, the leader in high complexity hereditary disease testing, today announced that it has entered into a…

Technology-Driven Precision Medicine Company Variantyx Secures $41.5M in Funding

  • Published on: February 12, 2022
  • News
Funding Round is Led by New Era Capital Partners and Includes Peregrine Ventures, Robert Bosch Venture Capital, 20/20 HealthCare Partners,…

Variantyx and Robert-Bosch Hospital team up to improve personalized oncology treatment

  • Published on: November 12, 2021
  • News
STUTTGART, Germany, Nov. 15, 2021  PRNewswire Robert Bosch Venture Capital GmbH, the corporate venture capital company of the Bosch Group, has…

Variantyx Expands Into Prenatal, Cancer Testing

  • Published on: May 11, 2021
May 11, 2021 Variantyx, a genetic testing company offering clinical whole-genome sequencing-based assays, is expanding its menu to include prenatal…